EBRO 2017

Vault recurrence

• Danish Endometrial Cancer Study – 1166 patients, surgery alone – Vaginal recurrence: low risk 6.3%, intermediate risk 22% – Curative treatment: 100% CR, 74% cured

• Must give sufficient dose (>65 Gy) – EBRT boost – Interstitial boost – IMRT

Ørtoft G, et al. Int J Gynecol Cancer. 2013; 23(8):1429-37